XML 89 R23.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Note P - Share-based Compensation
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]

NOTE P—SHARE-BASED COMPENSATION

  

Equity Plans 

                          

The Company’s board of directors and stockholders approved the following equity plans:

  

 

the 1998 Share Incentive Plan

 

 

the 2000 Share Incentive Plan

  

 

the 2004 Share Incentive Plan

  

 

the 2006 Share Incentive Plan

  

 

the Amended and Restated 2013 Equity Incentive Plan (“2013 Plan”)

  

The Company issued stock options, restricted stock awards (“RSAs”) and restricted stock units (“RSUs”) to employees, consultants and non-employee directors. Stock option awards generally vest over a four year period and have a maximum term of ten years. Stock options under these plans have been granted with an exercise price equal to the fair market value on the date of the grant. Nonqualified and Incentive Stock Options, RSAs and RSUs may be granted from these plans. Prior to the Company’s initial public offering in September 2013, the fair market value of the Company’s stock had been historically determined by the board of directors and from time to time with the assistance of third party valuation specialists.

  

Stock Options 

  

Options have been granted to the Company’s employees under the five incentive plans and generally become exercisable as to 25% of the shares on the first anniversary date following the date of grant and semi-annually thereafter. All options expire ten years after the date of grant.

  

The following is a summary of option activity (in thousands, except per share data):

  

                   

Weighted

           

Weighted

         
           

Weighted

   

Average

           

Average

         
           

Average

   

Share Price

   

Weighted

   

Remaining

   

Aggregate

 
   

Number of

   

Exercise

   

on Date of

   

Average

   

Contractual

   

Intrinsic

 
   

shares

   

Price

   

Exercise

   

Fair Value

   

Life

   

Value

 
   

(in thousands, except price data)

 

Outstanding, January 1, 2019

    287     $ 10.19             $ 5.31             $ 1,503  

Exercised

    (4 )     7.79     $ 12.91       3.95               15  

Forfeited

    (2 )     12.20               6.08               2  

Outstanding, December 31, 2019

    281     $ 10.21             $ 5.32       3.87       573  

Exercisable, December 31, 2019

    281     $ 10.21                       3.87       573  

Vested and expected to vest

    281     $ 10.21                       3.87     $ 573  

 

As of December 31, 2019, there was no unrecognized stock option expense.

 

Restricted Stock Unit/Awards

  

The following is a summary of RSU/RSA activity (in thousands, except per share data):

  

           

Weighted

                 
           

Average Share

   

Weighted

   

Aggregate

 
   

Number of

   

Price on Date

   

Average Fair

   

Intrinsic

 
   

shares

   

of Release

   

Value

   

Value

 
   

(in thousands, except price data)

 

Outstanding at January 1, 2019

    826             $ 32.07     $ 12,744  

Granted

    445               13.30       6  

Released

    (452 )   $ 25.95       25.95       6  

Cancelled/Forfeited

    (49 )             26.17       584  

Outstanding, December 31, 2019

    770               25.18       9,143  

Vested and expected to vest

    770             $ 25.18     $ 9,143  

 

The aggregate intrinsic value of RSUs and RSAs outstanding at December 31, 2019 was $9.8 million. Unrecognized compensation expense related to these RSUs and RSAs at December 31, 2019 was $16.8 million. This expense is expected to be recognized over 1.99 years.

  

Share-Based Compensation 

  

The Company recognizes compensation expense on a straight-line basis over the applicable vesting term of the award and expense is adjusted as forfeitures occur.

  

In 2014, the Company ceased issuing stock options and began issuing RSUs and RSAs as share-based compensation to employees. The Company estimates the fair value of RSUs and RSAs at the fair market value on the grant date.

  

Employee share-based compensation expenses recognized for the years ended December 31, were as follows (in thousands):

  

Share-Based compensation - by expense type:

  

   

2019

   

2018

   

2017

 

Cost of goods sold

  $ 772     $ 795     $ 461  

Research and development

    2,557       2,419       1,496  

Sales and marketing

    1,070       925       481  

General and administrative

    7,405       6,981       5,357  

Total share-based compensation expense

  $ 11,804     $ 11,120     $ 7,795  

 

Share-Based compensation - by award type:

  

   

2019

   

2018

   

2017

 

Employee stock options

  $     $ 12     $ 853  

Restricted stock units

    11,804       11,108       6,942  

Total share-based compensation expense

  $ 11,804     $ 11,120     $ 7,795